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ABSTRACT
Aims To examine the efficacy of a brief intervention delivered by a therapist (TBI) or a computer (CBI) in preventing
cannabis use among adolescents in urban primary care clinics.Design A randomized controlled trial comparing: CBI
and TBI versus control. Setting Urban primary care clinics in the United States. Participants Research staff
recruited 714 adolescents (aged 12–18 years) who reported no life-time cannabis use on a screening survey for this
study, which included a baseline survey, randomization (stratified by gender and grade) to conditions (control; CBI; TBI)
and 3-, 6- and 12-month assessments. Measurements Using an intent-to-treat approach, primary outcomes were
cannabis use (any, frequency); secondary outcomes included frequency of other drug use, severity of alcohol use and
frequency of delinquency (among 85% completing follow-ups). Findings Compared with controls, CBI participants
had significantly lower rates of any cannabis use over 12 months (24.16%, 16.82%, respectively, P < 0.05), frequency
of cannabis use at 3 and 6months (P < 0.05) and other drug use at 3months (P < 0.01). Compared with controls, TBI
participants did not differ in cannabis use or frequency, but had significantly less other drug use at 3months (P < 0.05),
alcohol use at 6 months (P < 0.01) and delinquency at 3 months (P < 0.01). Conclusions Among adolescents in
urban primary care in the United States, a computer brief intervention appeared to prevent and reduce cannabis use.
Both computer and therapist delivered brief interventions appeared to have small effects in reducing other risk
behaviors, but these dissipated over time.
Key words Adolescent, alcohol, brief intervention, cannabis, computerized, delinquency, drug, prevention,
primary care, urban.
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INTRODUCTION
Although, in the United States, alcohol is the most preva-
lent substance used by adolescents, cannabis is the most
prevalent illicit drug, with rates increasing with age [1].
Non-medical use of prescription drugs is the next most
commonly reported substance [1]. Earlier age of canna-
bis use increases the risk for other drug use, psychosocial
problems (e.g. delinquency) and the development of sub-
stance use disorders [2–4].
Traditionally, multi-session substance use prevention
programs have been delivered in schools, with evidenced-
based programs for alcohol, cannabis and illicit drug use
[5–13]. Findings from a meta-analysis suggest that uni-
versal programs were more effective for low base rates of
use (e.g. tobacco, marijuana) and selective or indicated
programs were more effective for high base rates of use
(e.g. alcohol) [13]. School-based prevention programs
have limited ability to reach youth who have dropped out
of school or attend sporadically.
A visit to a primary care clinic increases the reach of
prevention programs and may provide a ‘teachable
moment’ for brief interventions (BIs), increasing adoles-
cents’ receptivity to interventions [14]. In order to reduce
health disparities in access to primary care services
among socio-economically disadvantaged populations,
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the US government has established federally qualified
health clinics (FQHCs). BIs encompass principles of harm
reduction and motivational interviewing, which may be
particularly well suited for adolescents [14,15].
The application of BIs focused on universal prevention
among non-using youth is generally lacking. Prior BI
research has taken a selective or indicated approach, with
meta-analyses demonstrating efficacy [16]. For example,
among adolescent drinkers in primary care, therapist BIs
decrease alcohol misuse [17–21]. Among drug users,
there are a few promising pilot studies of therapist BIs
[18,22–24] and an effective trial in the Czech Republic
[21]. A prior paper from the study described in this paper
showed that among youth using cannabis, a therapist BI
reduced driving under the influence of cannabis, but did
not affect use [25]. A recent study found a universal
prevention-focused therapist BI for adolescent substance
use was not efficacious, despite the fact that content was
adapted from a previously demonstrated efficacious selec-
tive prevention-focused therapist BI [26–28].
Using computers for the assessment and delivery of
universal prevention-focused BIs could have considerable
public health impact. Although such studies are lacking
among adolescents in primary care, among adolescents
in the emergency department (ED) [29] and college stu-
dents [30,31], universal prevention-focused, computer-
delivered alcohol BIs are effective in the short term and/or
with at-risk subgroups of participants. A prior manu-
script from the study described in this paper examining
cannabis users showed that a selective computer BI
decreased other drug use and cannabis-related conse-
quences but not cannabis use [25].
This paper presents data from a randomized con-
trolled trial (RCT) examining the efficacy of universal
prevention-focused BIs (therapist- or computer-delivered)
in comparison to a control condition among adolescents
(aged 12–18 years) who had not initiated cannabis use
presenting to urban FQHCs. Preliminary outcome vari-
ables measured at post-test included perceived risk, self-
efficacy and intention to use. The primary outcome
measure was initiation and frequency of cannabis use;
the secondary outcome measures were frequency of
other drug use, severity of alcohol use and frequency of
delinquency. Hypotheses were that participants in the BIs
would report less cannabis, alcohol, other drug use (illicit
and non-medical prescription) and delinquency than
controls at 3-, 6- and 12-month follow-ups.
METHOD
Design
Project Chill was conducted at seven urban FQHCs in the
Midwest (April 2007–December 2009). Adolescents
(aged 12–18 years) self-administered a computerized
screening survey (with audio). Participants who had not
initiated cannabis use were enrolled in the RCT, consist-
ing of a baseline assessment, randomization to one of
three conditions (computer BI, therapist BI or control)
and follow-up assessments at 3, 6 and 12 months. Par-
ticipants reporting past-year cannabis use were enrolled
into a parallel trial reported on elsewhere [25]. The study
was approved by the University of Michigan’s Institu-
tional Review Board (IRB) for Human Subjects and we
obtained a Certificate of Confidentiality.
Procedures
On days containing a greater concentration of adolescent
appointments, research staff recruited patients in treat-
ment or waiting rooms. A two-phase written assent
(youth aged12–17years) and/or consent (youth aged18,
parents of youth aged 12–17) procedure was used for the
screening and RCT. Participants self-administered the
10-minute computer screening survey and received a
token$1.00gift. Initially (April 2007–July2008), partici-
pantswho reported no life-time cannabis usewere eligible
for theRCT. In order to increase the proportion of males in
the RCT and slow participant accrual, halfway through
the study (July 2008–December 2009) 50% of the males
and 10% of the females with no prior cannabis use were
selected randomly for the RCT, after which time
enrollment ended as planned based on funding. Then,
youth completed a 25-minute baseline computer survey
($20 remuneration) and provided a urine sample for drug
testing ($5). Participants were assigned randomly to con-
ditions by research staff using a computerized algorithm,
whichwasmonitored by the project coordinator and data
manager to ensure that staff could notmanipulate assign-
ment.Randomizationwas stratifiedbygender (in blocks of
21; sevenper group) andgrade (6–8th; 9thandup includ-
ing dropouts). The computerized post-test was adminis-
tered following the BIs. Research staff contacted youth
(e.g. telephone call, text, e-mail or private messaging via
social networking sites) to schedule follow-ups, which
occurred at primary care offices (85%), homes (7%), other
community locations (6%) or by telephone (2%). Youth
received remuneration of $25, $30 and $35 at each
assessment, respectively (and $5 for a urine sample at
each follow-up). Follow-up staff were blinded to condition
assignment.
Measures
In addition to demographic items [i.e. age, gender, race,
ethnicity, grade level (6–8th; 9th and up including drop-
outs), grades in school (mostlyAs,As andBs,mostlyBs, Bs
and Cs, mostly Cs, Cs and Ds, mostly Ds, Ds and Fs, mostly
Fs)] [32,33], validated measures are described below.
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Post-test preliminary outcomes
Perceived risk. Two items [34] were summed to indicate
perceived risk of occasional and regular cannabis use
(r = 0.54). Response choices included: no (0), slight (1),
moderate (2) and great (3).
Self-efficacy. Confidence in refusing cannabis use in three
situations (i.e. party, home alone and feeling sad or bored,
hanging out at a friend’s house) [35] was assessed by
summing responses to a five-point Likert scale [ranging
from ‘not at all sure I could say no’ (1) to ‘completely sure
I could say no’ (5) (α = 0.86)].
Intention to use. A single item assessed intention to use
cannabis in the next 3 months, with responses ranging
from ‘strongly disagree’ (1) to ‘strongly agree’ (4) [35].
Primary outcomes
Cannabis. Cannabis (e.g. marijuana, weed, pot) use fre-
quency (past 3 months) was measured using a question
from the Add Health study [32,33]. Response choices
were: never, 1–2 days, once a month or less, 2–3 days per
month, 1–2 days per week, 3–5 days per week and every
day or almost every day. Variables included any cannabis
use and frequency of use (range 0–6).
Secondary outcomes
Alcohol. The Alcohol Use Disorders Identification Test—
consumption (AUDIT-C) [36] was used to assess fre-
quency, quantity and heavy drinking (five or more) [37]
in the past 3 months. During piloting, youth indicated
that question 1 response options [never (0), monthly or
less (1), two to four times a month (2), two to three times
aweek (3), four ormore times aweek (4)] were confusing;
thus, we substituted the response options for question 3
[never (0), less thanmonthly (1), monthly (2), weekly (3),
daily or almost daily (4)]. For quantity, the responses
were: (0) none, (1) one to two, (2) three to four, (3) five to
six, (4) seven to nine (5) and 10 or more. Items were
summed to create an alcohol use severity scale (range
0−13).
Other drugs. Illicit and non-medical prescription drug use
(on your ownwithout a doctor telling you to take them) in
the past 3 months was measured using questions from
the Add Health study [32,33]. Illicit drugs included:
inhalants, cocaine, heroin and other hallucinogens
(e.g. ecstasy). Non-medical prescription drugs included:
painkillers/opiates (e.g. codeine); stimulants (e.g. Ritalin);
and sedatives (e.g. Xanax). Response options ranged from
0–6: never, 1–2 days, once a month or less, 2–3 days per
month, 1–2 days per week, 3–5 days per week, every day
or almost every day. Items were summed to create a fre-
quency of other drug use variable (range 0–42).
Delinquency. Ten items assessing frequency of violent
and non-violent delinquency in the past 3 months [38]
(e.g. physical fighting, stealing, selling drugs) were
summed, with responses ranging from 0 to 10 or more
times (α = 0.85; range 0–100).
Project Chill BIs
BIswere conducted in a private roomand could be paused
to allow for medical care. The BIs integrated motivational
interviewing (MI) spirit and techniques [14,15,39],
emphasizing personal responsibility, supporting self-
efficacy, eliciting commitment talk for avoiding cannabis
use and change talk for reducing alcohol, other drugs and
delinquency (see Table 1). The BIs also included norma-
tive resetting and role-play scenarios. Cultural relevance
to address the study population (∼50% African Ameri-
can) was incorporated into the content based on feedback
from focus testing, including providing diversity in
language (key messages, scripts for CBI), item-listed
checkboxes (e.g. goals, reasons to avoid using) and sce-
nario topics.
TBI. Therapists were trained inMI [14,15], including the
use of rulers to increase self-efficacy and commitment
talk for abstinence/reduction of other risk behaviors
(average length = 38 minutes, standard deviation = 14).
A computer displayed tailored feedback and prompt
content. Fidelity was monitored by audio-taping and pro-
viding feedback via regular individual and group super-
vision. A random sample of tapes was coded (25.8%,
n = 61) for therapist competence [global rating of MI
therapist (GROMIT); 18 items, α = 0.94] [40] and
content adherence (15 items, α = 0.80; developed for this
study) using a seven-point Likert scale (ranging from 1,
‘very poor’ to 7, ‘expert mastery’). Mean scores were gen-
erally acceptable for the GROMIT, indicatingMI spirit and
skill [4.95; standard deviation (SD) = 0.58; range 4–6]
and content adherence (3.85; SD = 0.40; range 3–6),
indicating delivery of sections.
CBI. Using touch-screens and headphones for audio, the
CBI was an animated, interactive program (average
length = 33 minutes, standard deviation = 13) delivered
by a virtual therapist, who provided affirmations and
summaries. Guided by a buddy chosen by participants,
the role-play scenarios showed characters in risky
situations, with progression over time in various conse-
quences, eliciting participant interaction and role-
modeling positive choices.
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Control. Participants in the control (and the BIs) were
given a brochure containing warning signs of problems
with cannabis and community resources (e.g. substance
use, mental health and leisure activities).
Data analysis
SAS version 9.2 was used for analyses. Descriptive
data are presented regarding enrollment and baseline
Table 1 Key elements of project CHILL prevention interventions.
Key elements Goal of element
Computer (C)- and therapist (T)-specific content or
both (B)
What are we going to do • Establish rapport
• Explain purpose to talk about cannabis use
C: Virtual therapist; participant selects buddy
T: Therapist introduction
What’s important to you:
goals and values
• Review and elaborate on goals and values
• Begin to develop discrepancy between
goals/values and current behavior by
exploring how cannabis use fits in with
goals/values
B: 3 goals listed
C: Summary of goals
T: Brief discussion of goals
Where do I fit in: normative
feedback
• Compare survey responses for use of
cannabis and alcohol to norms for age and
gender
• Raise concern by providing feedback about
the association between cannabis and other
risk behaviors (e.g. alcohol, other drugs) and
consequences (e.g. violence, injury,
delinquency, arrests)
• Explore potential impact of use on
goals/values, strengthening commitment talk
for avoiding/reducing use
B: Gender/age appropriate graphs shown on
screen
B: Reviewed in a matter-of-fact,
non-judgmental manner
T: Discuss how currently or in the future could
impact goals
C: Ask if think affects goals, check response on
screen; reflective summary statements
provided
C: Pictorial illustrations fading in and out to
increase salience during messages
You decide: reasons for
avoiding using/reasons
for using
• Elicit reasons to avoid using cannabis
• Explore reasons why other kids use cannabis
• Elicit and affirm commitment talk
• Support self-efficacy for avoiding use
• Support avoiding use by exploring potential
impact of use on future goals/values
• Roll with resistance
• Emphasize participant responsibility for
making choices
B: Reasons for avoiding cannabis use (long list)
and reasons for using (short list) presented
on screen for participant to check
T: Use motivational interviewing (MI) strategies
to make a connection between reasons to
avoid these behaviors and goals
C: Summaries of the reasons checked on the
screen. Participant checks which of goals
could be affected by use, which is
summarized
What’s next:
6 role plays
• Practice 6 scenarios which were selected by
the computer based on gender and risk profile
obtained from assessment
• Role-plays focus on: refusal skills with low
peer pressure, refusal skills with high peer
pressure, driving high/drunk or riding with
someone high/drunk, delinquency, coping
with boredom, refusal skills focusing on
consequences of use
B: Parallel role-play scenarios
T: Options are discussed to provide tools for
risky scenarios
C: Animated video situations viewed with
buddy. Decision points where participant
chooses the next action. If participants
‘choose’ a negative choice (use), the buddy
gives feedback on consequences in relation to
goals. Participant chooses a better option,
which is then animated
Scenarios show progression in consequences
for characters who use and don’t use
What we covered: summary
of session
• Provide participant with summary of goals,
behaviors, reasons to stay away from
cannabis
• Strengthen commitment to avoid using
• Support self-efficacy
• Review key messages and community
resources handout (e.g. mentor, psychological
services, leisure activities)
• Identify one next step in avoiding cannabis
T: Summary to reinforce commitment talk;
support/ advice for their ‘plan’. Review
community resources with an emphasis on
risk profile
C: Summaries of goals and reasons checked to
stay away from cannabis. Review of key
prevention messages; encourages review of
the community resources handout
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characteristics by condition assignment; bivariate analy-
ses were conducted to examine equivalence of groups at
baseline (χ2; t-tests). Preliminary outcome analyses
examined within condition (TBI, CBI) changes from base-
line to post-test on perceived risk, self-efficacy and inten-
tions (using the pairedWilcoxon’s signed-rank test due to
skewed variable distributions).
Study aims were to prevent or delay initiation of
cannabis use and reduce the extent of involvement with
cannabis use, alcohol use, other drug use and delin-
quency. Although 97% received their assigned condi-
tion, an intent-to-treat approach was used (e.g. all
randomized participants included regardless of whether
condition was received). Participants missing at
follow-up are not included in the analyses; however,
follow-up rates exceeded 85% for all conditions over
time and attrition analyses showed that baseline vari-
ables were not significantly related to follow-up comple-
tion, suggesting that the data were missing at random.
First, the percentage point difference for any cannabis
use was compared by conditions (TBI, CBI) versus
control at each time-point (3, 6 and 12 months), as well
as cumulatively over 12 months, using Fisher’s exact
test (with 95% confidence intervals). Secondly, regres-
sion analyses (i.e. negative binominal or Poisson models
based on distribution) were conducted to predict con-
tinuous primary (cannabis use frequency) and second-
ary (i.e. other drug use frequency, alcohol use severity
and delinquency frequency) outcomes at 3, 6 and 12
months. Independent variables included baseline levels
of the variable examined and condition (TBI versus
control, CBI versus control). The study was not powered
to detect differences between BIs. Thirdly, for conserva-
tive purposes, we repeated the regression analyses
described above, controlling for baseline variables:
gender, grade level (6–8th; 9th and up including drop-
outs), Hispanic ethnicity, race (African American versus
other) and failing grades (D and below or dropped out).
Age was not included, as it was correlated 0.91 with
grade level.
To achieve 80% power, n = 199 per group were
needed to detect a 10% difference in outcomes. Cohen’s
effect sizes [38] were calculated for significant effects.
Effect sizes of d = 0.10 are considered clinically meaning-
ful in the prevention literature [41].
RESULTS
Participants
Overall, 1416 youth were screened (Fig. 1). Males were
more likely to refuse participation in the screening than
females (18.0 and 12.9%, respectively; χ2(1) = 8.18,
P < 0.05). Also, Caucasians were more likely to refuse
than African Americans and other races (21.9, 12.8 and
15.6%, respectively; χ2(2) = 14.72, P < 0.001).
Among those screened, 714 reported no prior canna-
bis use, completed the baseline and were enrolled into the
RCT. Although no gender differences were observed for
participation in the baseline (3.6% male, 3.7% female;
χ2(1) = 0.0157, P > 0.05), Caucasians were more likely to
refuse thanwere AfricanAmericans and other races (6.0,
3.9 and 1.3%, respectively; χ2(2) = 6.86 and P < 0.05). No
other information could be gathered on those who
refused without written informed consent. Baseline char-
acteristics were examined for equivalence by condition;
age and grade level were significantly different by condi-
tion assignment (Table 2). Note that participants report-
ing past-year cannabis use (n = 366; see [25]) or
cannabis use that occurred greater than 1 year ago
(n = 31) were excluded from the prevention study.
Most youth (93.4%; 667 of 714) completed their con-
dition immediately orwithin 2weeks (n = 24); youthwho
did not receive their BI (n = 23) were included in follow-
ups. Follow-up rates exceeded 85% at 3, 6 and 12
months. χ2 analyses comparing attrition rates by group
showed no evidence of differential drop-out by condition
at 6 or 12months (P values >0.05). At 3months, the TBI
group had significantly lower follow-up rates than the
control (85.4 versus 92.3%; χ2(1) = 5.61, P < 0.05); attri-
tion did not differ at 3 months for the CBI versus control.
Comparisons of those completing follow-ups at 3, 6 and
12 months with those who did not complete follow-ups
were not significant for variables shown in Table 2.
Concordance between past 3-month self-report and
urine drug screen for cannabis was excellent at baseline
(99.4%). At 3, 6 and 12 months, agreement remained
high (99.0%); thus, self-report was used for analyses.
Preliminary outcomes
At post-test (Table 3), significant increases were noted in
perceived risk (for the CBI but not TBI) and in self-efficacy
(for the CBI and TBI). No significant changes were found
for behavioral intentions, probably because at base-
line most adolescents reported ‘strongly disagree’ for
intention to use.
Primary and secondary outcomes
Cannabis use
Table 4 shows the point prevalence of any cannabis use
by condition over time. For the CBI, although the point
prevalence did not differ at each time-point, the cumula-
tive prevalence over 12months was significantly lower in
the CBI compared to the control. The point prevalence of
cannabis use did not differ for the TBI versus the control.
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Frequency outcomes: cannabis, other drugs,
alcohol, delinquency
Models are presented that do not control for demograph-
ics (Table 5). Compared to controls, participants in the
CBI showed significantly less cannabis use at 3 and 6
months (d = 0.12 and 0.14, respectively) and other drug
use at 3 months (d = 0.09); the CBI did not affect alcohol
use or delinquency (Table 5). Although participants in
the TBI did not differ significantly from controls in can-
nabis use, participants in theTBI showed significantly less
other drug use at 3 months (d = 0.03), delinquency at 3
months (d = 0.36) and alcohol use at 6months (d = 0.14)
compared to controls. No significant effects were
observed at 12 months.
Additional models controlled for demographics (i.e.
gender, grade level, race, failing grades, ethnicity;
Table 6). Findings for the CBI were identical, as reported
above. Findings for the TBI were similar, with the excep-
tion that the efficacy of theTBI on other drug use was not
Assessed for Eligibility
n = 1813 (94.4%)
Allocated to CBI: n = 247
• Received intervention: n = 239
(96.8%)
• Did not receive intervention: n = 8
(3.2%)
- Did not return w/in 2 weeks 
(n = 6)
- Interview was too long (n = 2)
Allocated to Control: n = 234
• Received intervention: n = 229
(97.9%)
• Did not receive intervention: 
n = 5 (2.1%)
- Did not want to stay (n = 5)
Completed Baseline & Randomized 
n = 714 (84.1%)
Approached
n = 1664 (91.8%)
Missed: n = 149 (8.2%)
• RA occupied with another participants: n = 106 (71.1%)
• Left clinic before RA approached: n = 18 (12.1%)
• Other: n = 25 (16.8%) 
Refused: n = 248 (14.9%) 
• Didn’t want to participate: n = 90 (36.3%)
• Didn’t have time: n = 43 (17.3%)
• Family refused access: n = 20 (8.1%)
• Left clinic before completed screen: n = 51 (20.6%)
• Other: n = 44 (17.7%)
Screened
n = 1416 (85.1%)
Meet Criteria
(No prior cannabis use)
n = 849 (60.0%)
Excluded: n = 107 (12.6%)
• Sibling in household: n = 78 (72.9%)
• Other: n = 29 (27.1%)
Refused: n = 28 (3.3%)
• Did not return within 2 weeks: n = 15 (53.6%)
• Other: n = 13 (46.4%)
Allocated to TBI: n = 233
• Received intervention: n = 226
(97.0%)
• Did not receive intervention: n = 7
(3.0%)
- Did not return w/in 2 weeks
(n = 4)
- Refused to participate (n = 3)
Ineligible: n = 567 (40.0%)
• Past year cannabis use: n = 366 (64.5%)
• Prior cannabis use (> 1 year ago): n = 31 (5.5%)
• Not randomly selected for inclusion based on gender: n = 170 (30.0%)
All Patients
Age 12-18 years in sample frame
n = 1920 Excluded: n = 107 (5.6%)
• No parent or guardian: n = 43 (40.2%)
• Insufficient cognitive orientation to give consent: n = 13 (12.1%)
• Sibling in same household in study: n = 14 (13.1%)
• Other: n = 37 (34.6%)
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Figure 1 Study enrollment
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significant. Regarding demographics in general, cannabis
use, other drug use and delinquency was related posi-
tively to male gender, high school grade level or dropping
out, African American race and failing grades. Alcohol
use was related significantly to high school grade level or
dropping out. AfricanAmerican racewas associated posi-
tively with marijuana use and delinquency, whereas
other race was associated positively with other drug use
and alcohol use.
DISCUSSION
To our knowledge, this study is the first to use a universal
prevention approach to examine the potential efficacy of
BIs among adolescents in primary care who have yet to
initiate cannabis use. Reflecting the increased use and
subsequent salience of technology among adolescents,
the CBI was efficacious in preventing cannabis use and
reducing involvement with cannabis and other drugs,
with small but clinically meaningful effect sizes (0.12–
0.14). Given demands placed upon medical staff, using
computers for delivery of BIs could facilitate translation
into routine practice at FQHCs. The TBI was efficacious in
attenuating risk behaviors associated with cannabis use
in the short term, namely alcohol, other drug use and
delinquency, with effect sizes ranging from 0.11 to 0.36;
however, the TBI did not prevent cannabis use. These
findings are consistent with a prior paper from this study
3M: CBI
• Completed: n = 220 (89.1%)
• Lost to follow-up: n = 27 
(10.9%)
- Unable to locate (n = 6)
- In jail (n = 2)
- Refused (n = 2)
- Not return calls/Other 
(n = 17)
3M: TBI
• Completed: n = 199 (85.4%)
• Lost to follow-up: n = 34
(14.6%)
- Unable to locate (n = 8)
- Died (n = 2)
- Refused (n = 9)
- Not return calls/Other 
(n = 15)
3M: Control
• Completed: n = 216 (92.3%)
• Lost to follow-up: n = 18
(7.7%)
- Unable to locate (n = 1)
- In jail (n = 1)
- Refused (n = 3)
- Not return calls/Other 
(n = 13)
CBI
• Analysed: n = 247
• Excluded due to missing 
data: 
- 3 month analysis (n = 27)
- 6 month analysis (n = 29)
- 12 month analysis (n = 27)
TBI
• Analysed: n = 233
• Excluded due to missing 
data: 
- 3 month analysis (n = 34)
- 6 month analysis (n = 33)
- 12 month analysis (n = 32)
Control
• Analysed: n = 234
• Excluded due to missing 
data: 
- 3 month analysis (n = 18)
- 6 month analysis (n = 23)
- 12 month analysis (n = 27)
6M: CBI
• Completed: n = 218 (88.3%)
• Lost to follow-up: n = 29 
(11.7%)
- Unable to locate (n = 8)
- In jail (n = 2)
- Refused (n = 3)
- Not return calls/Other 
(n = 16)
12M: CBI
• Completed: n = 220 (89.1%)
• Lost to follow-up: n = 27 
(10.9%)
- Unable to locate (n = 6)
- In jail (n = 1)
- Refused (n = 6)
- Not return calls/Other 
(n = 14)
6M: TBI
• Completed: n = 200 (85.8%)
• Lost to follow-up: n = 33
(14.2%)
- Unable to locate (n = 9)
- Refused (n = 5)
- Not return calls/Other 
(n = 19)
12M: TBI
• Completed: n = 201 (86.3%)
• Lost to follow-up: n = 32 
(13.7%)
- Unable to locate (n = 8)
- Refused (n = 10)
- Not return calls/Other 
(n = 14)
6M: Control
• Completed: n = 211 (90.2%)
• Lost to follow-up: n = 23 
(9.8%)
- Unable to locate (n = 7)
- Refused (n = 3)
- Not return calls/Other 
(n = 13)
12M: Control
• Completed: n = 207 (88.5%)
• Lost to follow-up: n = 27 
(11.5%)
- Unable to locate (n = 7)
- In jail (n = 1)
- Refused (n = 4)
- Not return calls/Other 
(n = 15)
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Completed Post-Test: CBI
n = 236 (95.5%)
Completed Post-Test: TBI
n = 224 (96.1%)
Completed Post-Test: Control
n = 206 (88.0%)
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Figure 1 Continued
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among cannabis users, which showed greater evidence
for the CBI than the TBI [25]. Conclusions regarding BI
efficacy vary based on substance, problem severity,
setting and deliverymechanism. For example, a universal
prevention-focused, computerized, alcohol BI among
college freshman showed greater effects for non-drinkers
than low-risk drinkers [30]; however, other studies have
found greater effects for selective or indicated prevention
samples (substance users) than universal prevention
samples [42]. Further, a recent review concluded that
TBIs were more effective than CBIs among college
students who misused alcohol [43].
Variation in BI content may also explain differences in
findings across studies. Although our BIs were conceptu-
alized to have parallel content, in practice the delivery
mechanism affected the content. Therapists were given
autonomy to focus the TBI based on participant interac-
tion; thus, the therapist may have placed greater empha-
sis on risk behaviors other than cannabis (e.g. half the
youth reported a least one act of delinquency), while the
CBI focused more consistently on cannabis use. In con-
trast, although tailored, the CBI the content was set a
priori, with greater emphasis on cannabis and the con-
nection to other risk behaviors, which was reflected in
significant increases at post-test in ratings of perceived
risk. Alternatively, although both BIs aimed to increase
self-efficacy and commitment talk for abstinence by pre-
senting hypothetical risk situations, the TBI was pre-
sented in discussion format whereas the CBI included
interactive videos modeling how youth could handle risk
situations to avoid potential consequences (e.g. health,
social, legal).
Future studies are needed to delineate the essential
elementsof computerand therapistBIsaddressinguniver-
sal substance use prevention among adolescents. For
instance, decisional balance exercises are associated with
poorer outcomes in one review and better outcomes in
another [43,44], perhaps reflecting differences in thera-
pist skills than specific content. Identification of therapist
behaviors that are associated with worse outcomes
is another important area of future research, with
Table 2 Baseline demographic and substance use characteristics by condition.
Background characteristics
Total TBI CBI Control
n = 714 n = 233 n = 247 n = 234
%/mean (SD) %/mean (SD) %/mean (SD) %/mean (SD)
Demographics
Male 43.0% 45.5% 44.5% 38.9%
African American race 63.7% 64.0% 62.4% 65.0%
Hispanic ethnicity 9.2% 10.8% 7.0% 9.8%
Age* 14.9 (1.9) 15.2 (1.8) 14.7 (1.9) 14.9 (2.1)
Grade levels 6–8* 36.5% 30.1% 40.1% 39.3%
Failing grades 17.1% 14.6% 16.6% 20.1%
Drug use behaviors
Other illegal drug use (ever) 6.9% 7.7% 7.3% 5.6%
Frequency 0.2 (1.0) 0.2 (1.0) 0.2 (0.8) 0.2 (1.1)
Alcohol use (ever) 12.0% 12.0% 10.5% 13.7%
Frequency 0.2 (0.5) 0.2 (0.5) 0.2 (0.6) 0.2 (0.5)
Delinquency (any) 47.5% 51.5% 47.4% 43.6%
Frequency 1.9 (4.3) 1.9 (3.5) 2.0 (4.9) 1.8 (4.3)
*P ≤ 0.05. CBI = computer brief intervention; TBI = therapist brief intervention; SD = standard deviation. Note the following variables definitions: (1)
race = African American versus other; (2) grade levels = 6–8th; 9th and up including dropouts; and (3) failing grades = Ds and below or dropped out.
Table 3 Within-condition (TBI, CBI) changes in perceived risk,
self-efficacy and intention to use.
Variable TBI (n = 236) CBI (n = 247)
Perceived risk
Baseline mean (SD) 2.21 (0.97) 2.33 (0.90)
Post-test mean (SD) 2.24 (0.90) 2.54 (0.72)
Difference in mean ( SD) 0.03 (0.85) 0.21 (0.74)
% Change in mean 1.4% 9.0% ***
Self-efficacy
Baseline mean (SD) 3.82 (1.59) 3.91 (1.51)
Post-test mean (SD) 4.17 (1.47) 4.36 (1.28)
Difference in mean 0.43 (1.32) 0.49 (1.32)
% Change in mean 9.2%*** 11.5%***
Intention to use
Baseline mean (SD) 1.21 (0.49) 1.23 (0.55)
Post-test mean (SD) 1.20 (0.55) 1.23 (0.55)
Difference in mean 0.01 (0.59) 0.01 (0.65)
% Change in mean 0.8% 0.8%
***P ≤ 0.001. n shown is for baseline; three therapist brief intervention
(TBI) participants did not complete the post-test and three computer brief
intervention (CBI) participants did not complete the post-test. SD = stand-
ard deviation.
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review studies suggesting that simple reflections and
directiveness are counterproductive [44,45] among
substance-using samples. In our study, it is unknown
whether such behaviors occurred in the TBI, whereas the
CBI was programmed so that it did not include such
behaviors.
Although findings for this study showed short-term
benefits of BIs, consistent with conclusions from reviews
regarding the efficacy of motivational interviewing based
BIs [46], effects were generally not sustained. Given that
the American Medical Association (AMA) recommends
that adolescents be asked at least annually about sub-
stance use [47], additional boosters could be delivered
during subsequent visits. In order to optimize effects, a
multi-modal approach could be utilized in which the
computer program could be initially provided for univer-
sal prevention, followed by therapist BIs to further explore
changes in risk behaviors over time.
Limitations
Several study limitations require attention. Self-report
data were collected, whichmay be prone to response bias.
Table 4 Efficacy of CBI and TBI (versus control) on any cannabis use over time.
Outcome
CBI
% (n)
Control
% (n)
Percentage-point
difference (95% CI)
Relative rate
(95% CI)
Point prevalence at 3 months 5.00 (11)a 7.87 (17)i −2.87 (−7.47–1.73) 0.64 (0.30–1.32)
Point prevalence at 6 months 5.96 (13)b 9.01 (19)j −3.05 (−8.02–1.94) 0.66 (0.34–1.31)
Point prevalence at 12 months 10.91 (24)c 14.01 (29)k −3.10 (−9.37–3.17) 0.78 (0.47–1.29)
Any use over 12 months 16.82 (37)d 24.16 (50)l −7.34 (−14.98–0.00)* 0.70 (0.48–1.00)
Outcome
TBI
% (n)
Control
% (n)
Percentage-point
difference (95% CI)
Relative rate
(95% CI)
Point prevalence at 3 months 6.53 (13)e 7.87 (17)i −1.34 (−6.31–3.63) 0.83 (0.42–1.66)
Point prevalence at 6 months 9.00 (18)f 9.00 (19)j 0.00 (−5.54–5.54) 1.00 (0.54–1.85)
Point prevalence at 12 months 10.95 (22)g 14.01 (29)k −3.06 (−9.46–3.34) 0.78 (0.46–1.31)
Any use over 12 months 20.90 (42)h 24.16 (50)l −3.26 (−11.36–4.84) 0.87 (0.60–1.24)
The relative rate is the percentage in the brief intervention (BI) group divided by control group. Use rates were calculated by participants who used
cannabis among those completing follow-up. CBI = computer brief intervention; TBI = therapist brief intervention; CI = confidence interval. a220; b218,
c220, d220, e199, f200, g201, h201, i216, j211, k207 and l207. *P < 0.05.
Table 5 Regression analyses: efficacy of TBI and CBI (versus control) on extent of substance use and delinquency over time.
Variable
3Ma 6Mb 12Mc
IRR (95%CI) IRR (95%CI) IRR (95%CI)
Cannabis use frequency
Computer 0.55 (0.30, 0.99)* 0.56 (0.34, 0.91)* 0.89 (0.60, 1.31)
Therapist 0.92 (0.55, 1.54) 0.65 (0.41, 1.04) 0.90 (0.61, 1.33)
Other drug use frequency
Baseline other drug use 1.20 (1.09, 1.32)*** 1.20 (1.09, 1.32)*** 1.42 (1.31, 1.53)**
Computer 0.48 (0.29, 0.79)** 0.94 (0.60, 1.48) 0.75 (0.38, 1.49)
Therapist 0.52 (0.31, 0.87)* 0.61 (0.36, 1.04) 0.86 (0.39, 1.92)
Alcohol use severity
Baseline alcohol use 3.00 (2.15, 4.19)*** 2.27 (1.73, 2.99)*** 2.32 (1.73, 3.11)***
Computer 0.86 (0.48, 1.55) 0.63 (0.39, 1.01) 0.82 (0.50, 1.34)
Therapist 1.23 (0.70, 2.18) 0.52 (0.32, 0.85)** 0.69 (0.42, 1.34)
Delinquency frequency
Baseline delinquency 1.25 (1.17,1.32)*** 1.23 (1.14, 1.33)*** 1.19 (1.12, 1.26)***
Computer 0.91 (0.63, 1.33) 1.15 (0.72, 1.84) 0.88 (0.55, 1.41)
Therapist 0.54 (0.36, 0.80)** 0.92 (0.58, 1.48) 0.98 (0.61, 1.57)
3M = 3-month follow-up; 6M = 6-month follow-up; 12M = 12-month follow-up; TBI = therapist brief intervention; CBI = computer brief intervention;
IRR = incident rate ratio; CI = confidence interval. IRR values >1.0 indicate variables associated positively with the outcome variable and values <1.0
indicate variables associated negatively with the outcome variable. Effect sizes: (1) cannabis use: CBI = 0.12 (3M) and 0.14 (6M); (2) other drug use:
CBI = 0.09 (3M); (3) alcohol use: TBI = 0.14 (3M); and (4) delinquency: TBI =0.36 (3M). an =635, bn =629, cn =628. *P < 0.05; **P < 0.01;
***P < 0.001.
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To increase the accuracy of self-report, we included
a urine drug screen (with excellent concordance),
participants’ self-administered data on computers, and
follow-up staff were ‘blinded’ to condition assignment
[48,49]. Although regular supervision was provided and
a computer was used to prompt section content for thera-
pists, a challenge inherent to the delivery of TBIs is fidel-
ity. Although follow-up rates were excellent (>85%),
substance use among those not completing follow-ups
was unknown; thus, analyses were limited to those com-
pleting follow-ups. Also, higher rates of attrition in the
TBI at 3 months could have affected findings. Replication
is required to determine generalizability to other samples
(e.g. Hispanics) and settings.
CONCLUSIONS
From a public health standpoint, findings from this uni-
versal prevention study suggest that a computer BI may
be particularly promising in deterring the use of cannabis
and other drugs in the short term. Findings for a therapist
BI were mixed, with no effects on cannabis use but short-
term effects on other risk behaviors. Future studies are
needed to identify critical components of BIs, including
the optimal combination of therapist and computer BIs
and timing of delivery of boosters at subsequent visits.
Clinical Trial registration
ClinicalTrials.gov Identifier NCT01329315.
Table 6 Regression analyses: efficacy of TBI and CBI (versus control) on extent of substance use and delinquency over time: control-
ling for baseline characteristics.
Variable
3Ma 6Mb 12Mc
IRR (95%CI) IRR (95%CI) IRR (95%CI)
Cannabis use frequency
Computer 0.53 (0.29, 0.95)* 0.61 (0.37, 0.99)* 0.86 (0.58, 1.27)
Therapist 0.84 (0.49, 1.42) 0.66 (0.41, 1.06) 0.94 (0.21, 4.18)
Gender 1.60 (1.00, 2.56) 1.63 (1.08, 2.46) 1.07 (0.77, 1.50)
Education 0.86 (0.53, 1.40) 0.41 (0.25, 0.67) 0.58 (0.40, 0.85)
Race group 2.61 (1.04, 6.56)* 4.85 (1.75, 13.45) 1.75 (0.97, 3.15)
Failing grade 0.44 (0.27, 0.73)** 0.30 (0.20, 0.45) 0.61 (0.42, 0.88)
Ethnicity 1.05 (0.35, 3.15) 1.43 (0.67, 3.08) 1.03 (0.57, 1.86)
Other drug use frequency
Baseline other drug use 1.26 (1.14, 1.39)*** 1.23 (1.12, 1.36)*** 1.32 (1.20, 1.46)***
Computer 0.52 (0.31, 0.86)* 0.97 (0.61, 1.55) 0.78 (0.38, 1.58)
Therapist 0.65 (0.39, 1.08) 0.63 (0.37, 1.07) 0.90 (0.39, 2.04)
Gender 0.23 (0.14, 0.41)*** 1.13 (0.73, 1.74) 1.27 (0.69, 2.33)
Education 2.56 (1.66, 3.94)*** 1.93 (1.19–3.16)* 1.92 (1.02, 3.59)*
Race group 0.32 (0.19, 0.54)*** 0.40 (0.24, 0.66)*** 0.86 (0.30, 2.48)
Failing grade 0.41 (0.26, 0.66)*** 0.36 (0.23, 0.55)*** 0.74 (0.31, 1.79)
Ethnicity 0.73 (0.37, 1.41) 0.64 (0.31, 1.32) 0.70 (0.23, 2.20)
Alcohol use severity
Baseline alcohol use 3.06 (2.15, 4.36)*** 2.05 (1.59, 2.65)*** 2.20 (1.67, 2.90)***
Computer 0.93 (0.52, 1.68) 0.66 (0.42, 1.04) 1.22 (0.75, 1.99)
Therapist 1.38 (0.78, 2.43) 0.57 (0.36, 0.91)* 1.36 (0.84, 2.23)
Gender 0.84 (0.51, 1.36) 0.90 (0.61, 1.34) 0.78 (0.52, 1.18)
Education 0.97 (0.58, 1.62) 0.53 (0.34, 0.84)** 0.46 (0.28, 0.76)**
Race group 0.76 (0.40, 1.44) 0.47 (0.29, 0.76)** 0.75 (0.43, 1.30)
Failing grade 0.58 (0.33, 1.02) 0.73 (0.47, 1.15) 0.94 (0.55, 1.60)
Ethnicity 1.75 (0.74, 4.15) 1.80 (0.96, 3.38) 1.57 (0.77, 3.18)
Delinquency frequency
Baseline delinquency 1.20 (1.13, 1.27)*** 1.21 (1.12, 1.31)*** 1.13 (1.06, 1.20)***
Computer 0.90 (0.62, 1.31) 0.94 (0.60, 1.48) 0.85 (0.53, 1.36)
Therapist 0.53 (0.36, 0.79)** 0.81 (0.51, 1.30) 1.03 (0.64, 1.65)
Gender 1.46 (1.07, 2.00)* 1.55 (1.07, 2.25)* 1.84 (1.24, 2.72)**
Education 1.75 (1.28, 2.40)** 0.92 (0.62, 1.37) 1.49 (1.01, 2.21)*
Race group 1.86 (1.10, 3.16)* 0.76 (0.44, 1.31) 0.99 (0.55, 1.78)
Failing grade 0.83 (0.56, 1.22) 0.74 (0.46, 1.19) 0.60 (0.36, 1.00)*
Ethnicity 1.19 (0.67, 2.09) 1.34 (0.66, 2.71) 1.05 (0.48, 2.30)
3M = 3-month follow-up; 6M = 6-month follow-up; 12M = 12-month follow-up; TBI = therapist brief intervention; CBI = computer brief intervention;
IRR = incident rate ratio; CI = confidence interval. IRR values >1.0 indicate variables associated positively with the outcome variable and values <1.0
indicate variables associated negatively with the outcome variable. *P < 0.05; **P < 0.01; ***P < 0.001; an = 635, bn = 629, cn = 628.
Efficacy of a brief cannabis universal prevention program 795
© 2013 Society for the Study of Addiction Addiction, 109, 786–797
Declaration of interests
None.
Acknowledgements
This project was funded by a grant (no. DA020075) from
the National Institute on Drug Abuse (NIDA). We would
like to thank project staff as well as the patients and
medical staff at Hamilton Community Health Centers and
Health Delivery Inc., and Mott Children’s Health Center
for their support of this project.
References
1. Johnston L. D., O’Malley P.M., Bachman J. G., Schulenberg J.
E.Monitoring the Future National Survey Results on Drug Use,
1975–2011. Volume I: Secondary School Students. Ann
Arbor: Institute for Social Research, The University of
Michigan; 2012.
2. Brook D. W., Brook J. S., Zhang C., Cohen P., Whiteman M.
Drug use and the risk of major depressive disorder, alcohol
dependence, and substance use disorders. Arch Gen Psychia-
try 2002; 59: 1039–44.
3. Lynskey M. T., Heath A. C., Bucholz K. K., Slutske W. S.,
Madden P. A., Nelson E. C. et al. Escalation of drug use in
early-onset cannabis users vs co-twin controls. JAMA 2003;
289: 427–33.
4. McCabe S. E., West B. T., Cranford J. A., Ross-Durow P.,
Young A., Teter C. J. et al. Medical misuse of controlled
medications among adolescents. Arch Pediatr Adolesc Med
2011; 165: 729–35.
5. Tobler N. S., Stratton H. H. Effectiveness of school-based
drug prevention programs: a meta-analysis of the research.
J Prim Prev 1997; 18: 71–128.
6. D’Amico E. J., Tucker J. S., Miles J. N. V., Zhou A. J., Shih R.
A., Green J. H. D. Preventing alcohol use with a voluntary
after-school program for middle school students: results
from a cluster randomized controlled trial of CHOICE. Prev
Sci 2012; 13: 415–25.
7. Hecht M. L., Marsiglia F. F., Elek E., Wagstaff D. A., Kulis S.,
Dustman P. et al. Culturally grounded substance use preven-
tion: an evaluation of the keepin’ it R.E.A.L. curriculum.
Prev Sci 2003; 4: 233–48.
8. Catalano R. F., Berglund M. L., Ryan J. A. M., Lonczak H. S.,
Hawkins J. D. Positive youth development in the United
States: research findings on evaluations of positive youth
development programs. Prev Treat 2002; 5: 1–111.
9. Hanley S., Ringwalt C., Ennett S. T., Vincus A. A., Bowling J.
M., Haws S. W. et al. The prevalence of evidence-based sub-
stance use prevention curricula in the nation’s elementary
schools. J Drug Educ 2010; 40: 51–60.
10. Conrod P. J., Castellanos-Ryan N., Strang J. Brief,
personality-targeted coping skills interventions and sur-
vival as a non-drug user over a 2-year period during adoles-
cence. Arch Gen Psychiatry 2010; 67: 85–93.
11. Sussman S., Sun P., Rohrbach L. A., Spruijt-Metz D. One-
year outcomes of a drug abuse prevention program for older
teens and emerging adults: evaluating a motivational inter-
viewing booster component.Health Psychol 2012; 31: 476–
85.
12. Faggiano F., Vigna-Taglianti F., Burkhart G., Bohrn K.,
Cuomo L., Gregori D. et al. The effectiveness of a school-
based substance abuse prevention program: 18-month
follow-up of the EU-Dap cluster randomized controlled trial.
Drug Alcohol Depend 2010; 108: 56–64.
13. Shamblen S. R., Derzon J. H. A preliminary study of the
population-adjusted effectiveness of substance abuse pre-
vention programming: towards making IOM program types
comparable. J Prim Prev 2009; 30: 89–107.
14. Monti P. M., Barnett N. P., Colby S. M., O’Leary T. A. Moti-
vational enhancement of alcohol-involved adolescents. In:
Monti P. M., Colby S. M., O’Leary T. A., editors. Adolescents,
Alcohol and Substance Abuse: Reaching Teens through Brief
Interventions, New York: Guilford Press; 2001, pp. 145–82.
15. Miller W. R., Rollnick S. Motivational Interviewing, 3rd edn.
Helping People for Change (Applications of Motivational Inter-
viewing). New York: Guilford Press; 2012.
16. Jensen C. D., Cushing C. C., Aylward B. S., Craig J.T., Sorell D.
M., Steele R. G. Effectiveness of motivational interviewing
interventions for adolescent substance use behavior
change: ameta-analytic review. J Consult Clin Psychol2011;
79: 433–40.
17. Bertholet N., Daeppen J. B., Weitlisbach V., Fleming M.,
Burnand B. Reduction of alcohol consumption by brief
intervention in primary care. Arch Intern Med 2005; 165:
986–95.
18. Mason M., Pate P., Drapkin M., Sozinho K. Motivational
interviewing integrated with social network counseling for
female adolescents: a randomized pilot study in urban
primary care. J Subst Abuse Treat 2011; 41: 148–55.
19. Millstein S. G., Marcell A. V. Screening and counseling for
adolescent alcohol use among primary care physicians in
the United States. Pediatrics 2003; 111: 114–25.
20. Ozer E. J., Tschann J. M., Pasch L. A., Flores E. Violence
perpetration across peer and partner relationships:
co-occurrence and longitudinal patterns among adoles-
cents. J Adolesc Health 2004; 34: 64–71.
21. Harris S. K., Csémy L., Sherritt L., Starostova O., Van Hook
S., Johnson J. et al. Computer-facilitated substance use
screening and brief advice for teens in primary care: an
international trial. Pediatrics 2012; 129: 1–12.
22. Haller D., Meynard A., Lefebvre D., Tylee A., Narring F.,
Broers B. Brief intervention addressing excessive cannabis
use in young people consulting their GP: a pilot study. Br J
Gen Pract 2009; 59: 166–72.
23. Knight J. R., Sherritt L., Van Hook S., Gates E. C., Levy S.,
Chang G. Motivational interviewing for adolescent sub-
stance use: a pilot study. J Adolesc Health 2005; 37: 167–9.
24. D’Amico E. J., Miles J. N., Stern S. A., Meredith L. S. Brief
motivational interviewing for teens at risk of substance use
consequences: a randomized pilot study in a primary care
clinic. J Subst Abuse Treat 2008; 35: 53–61.
25. WaltonM.A., Bohnert K., Resko S., Barry K.T., Chermack S.
T., Zucker R. A. et al. Computer and therapist based brief
interventions among cannabis-using adolescents present-
ing to primary care: one year outcomes.Drug Alcohol Depend
2013; 132: 646–53.
26. McCambridge J., Strang J. Development of a structured
generic drug intervention model for public health purposes:
a brief application of motivational interviewing with young
people. Drug Alcohol Rev 2003; 22: 391–9.
27. McCambridge J., Strang J. The efficacy of single-session
motivational interviewing in reducing drug consumption
and perceptions of drug-related risk and harm among
young people: results from a multi-site cluster randomized
trial. Addiction 2004; 99: 39–52.
796 Maureen A. Walton et al.
© 2013 Society for the Study of Addiction Addiction, 109, 786–797
28. McCambridge J., Strang J. Deterioration over time in effect of
motivational interviewing in reducing drug consumption
and related risk among young people. Addiction 2005; 100:
470–8.
29. Maio R. F., Shope J. T., Blow F. C., Gregor M. A., Zakrajsek J.
S., Weber J. E. et al. A randomized controlled trial of an
emergency department-based interactive computer
program to prevent alcohol misuse among injured adoles-
cents. Ann Emerg Med 2005; 45: 420–9.
30. Bingham C. R., Barretto A. I., Walton M. A., Bryant C. M.,
Shope J. T., Raghunathan T. E. Efficacy of a web-based, tai-
lored, alcohol prevention/intervention program for college
students: 3 month follow-up. J Drug Educ 2011; 41: 405–
30.
31. Kypri K., Langley J. D., Saunders J. B., Cashell-Smith M. L.,
Herbison P. Randomized controlled trial of web-based
alcohol screening and brief intervention in primary care.
Arch Intern Med 2008; 168: 530–6.
32. Sieving R. E., Beuhring T., Resnick M. D., Bearinger L. H.,
Shew M., Ireland M. et al. Development of adolescent
self-report measures from the National Longitudinal Study
of Adolescent Health. J Adolesc Health 2001; 28: 73–81.
33. Harris K., Florey F., Tabor J., Bearman P., Jones J., Udry J. The
National Longitudinal Study of Adolescent Health: research
design. 2003. Available at: http://www.cpc.unc.edu/
projects/addhealth/design (accessed 21 May 2008).
(Archived at http://www.webcitation.org/6Mcrg96q8 on
14 January 2014).
34. Johnston L. D., O’Malley P. M., Bachman P. M., Schulenberg
J. E. Monitoring the Future: National Results on Adolescent
Drug Use: Overview of key findings, 2003. Report no. NIH
Publication no. 04-5506. Bethesda, MD: National Institute
on Drug Abuse; 2004.
35. Ellickson P. L., Bell R. M. Prospects for Preventing Drug Use
among Young Adolescents. Santa Monica, CA: RAND Corpo-
ration; 1990.
36. Bush K., Kivlahan D. R., McDonell M. B., Fihn S. D., Bradley
K. A. TheAUDIT alcohol consumption questions (AUDIT-C):
an effective brief screening test for problem drinking.
Ambulatory Care Quality Improvement Project (ACQUIP).
Alcohol Use Disorders Identification Test. Arch Intern Med
1998; 158: 1789–95.
37. Chung T., Colby S. M., Barnett N. P., Monti P. M. Alcohol Use
Disorders Identification Test: factor structure in an adoles-
cent emergency department sample. Alcohol Clin Exp Res
2002; 26: 223–31.
38. ZimmermanM.A., Ramirez-Valles J., Zapert K.M.,Maton K.
I. A longitudinal study of stress-buffering effects for urban
African American male adolescent problem behaviors and
mental health. J Community Psychol 2000; 28: 17–33.
39. Baer J. S., Peterson P. L. Adolescents and young adults. In:
Miller W. R., Rollnick S., editors. Motivational Interviewing:
Preparing People for Change, 2nd edn. New York: Guilford
Press; 2002, pp. 320–32.
40. Moyers T. B. The Global Rating of Motivational Interviewing
Therapists. Center on Alcoholism, Substance Use, and
Addictions. 2004. Available at: http://casaa.unm.edu/
download/GROMIT.pdf (accessed 23 March 2009).
(Archived at http://www.webcitation.org/6MxRYOXnn
on 28 January 2014).
41. Gottfredson D. C., Wilson D. B. Characteristics of effective
school-based substance abuse prevention. Prev Sci 2003; 4:
27–38.
42. McCambridge J., Hunt C., Jenkins R. J., Strang J. Cluster
randomised trial of the effectiveness of motivational inter-
viewing for universal prevention. Drug Alcohol Depend
2011; 114: 177–84.
43. Carey K. B., Scott-Sheldon L. A. J., Elliott J. C., Garey L.,
Carey M. P. Face-to-face versus computer-delivered alcohol
interventions for college drinkers: a meta-analytic review,
1998 to 2010. Clin Psychol Rev 2012; 32: 690–703.
44. Apodaca T. R., Longabaugh R. Mechanisms of change
in motivational interviewing: a review and preliminary
evaluation of the evidence. Addiction 2008; 104: 705–
15.
45. Tollison S. J., Mastroleo N. R., Witkiewitz K., Lee C. M., Ray
A. E., Larimer M. E. The relationship between baseline
drinking status, peer motivational interviewing microskills,
and drinking outcomes in a brief alcohol intervention for
matriculation college students: a replication. Behav Ther
2013; 44: 137–51.
46. Smedslund G., Berg R. C., Hammerstrom K. T., Steiro A.,
Leiknes K. A., Dahl H.M. et al. Motivational interviewing for
substance abuse (Review). Cochrane Database Syst Rev 2011;
11: 1–128.
47. AmericanMedical Association. Guidelines for Adolescent Pre-
ventive Services (GAPS). Chicago, IL: American Medical
Association; 1997.
48. Brener N. D., Billy J. O., Grady W. R. Assessment of factors
affecting the validity of self-reported health-risk behavior
among adolescents: evidence from the scientific literature.
J Adolesc Health 2003; 33: 436–57.
49. Dennis M., Titus J. C., Diamond G., Donaldson J., Godley S.
H., Tims F. M. et al. The Cannabis Youth Treatment (CYT)
experiment: rationale, study design and analysis plans.
Addiction 2002; 97: 16–34.
Efficacy of a brief cannabis universal prevention program 797
© 2013 Society for the Study of Addiction Addiction, 109, 786–797
